Skip to Main Content

Paper Details

Impact of Genomic and Clinical Factors on Outcome of Children â¿¥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report.
3
2023
11q, A3973, ANBL00B1, ANBL0532, Children, DNA, MYCN, MYCN-, MYCN-nonamplified (, Neuroblastoma, Patients, RNA, Stage 3 Neuroblastoma, Tumors, UH, chromosome 11q, chromosome 1p or 11q, chromosome 5 or 9, neuroblastoma, patients, tumors
Author NameAffiliation
Michael D HogartyUniversity of Pennsylvania
Rochelle BagatellUniversity of Pennsylvania
  • 1 - 2

Datasets

Release 1.2